Results 101 to 110 of about 8,710 (181)

Efficacy and Safety of Sacubitril/Valsartan After Switching From Azilsartan in Essential Hypertensive Patients: Based on Home Blood Pressure Monitoring. [PDF]

J Clin Hypertens (Greenwich)
Iwashima Y, Sugiura M, Horio T, Yamamoto K, Takahashi N.   +4 more
europepmc   +1 more source

Chlorination of Amines by a Vanadium-Dependent Chloroperoxidase. [PDF]

ACS Catal
Gross EJ, Barthel SG, Brzezinski CU, Hessefort LZ, Bacsa J, Biegasiewicz KF.   +5 more
europepmc   +1 more source

1,3,4-oxadiazoles as inhibitors of the atypical member of the BET family bromodomain factor 3 from Trypanosoma cruzi (TcBDF3). [PDF]

Front Microbiol
Alonso VL, Escalante AM, Rodríguez Araya E, Frattini G, Tavernelli LE, Moreno DM, Furlan RLE, Serra E.   +7 more
europepmc   +1 more source

Exploring 1,3,4-oxadiazolyl sulfide derivatives as antidiabetic candidates: synthesis, antioxidant activity, SAR-study, molecular docking, and DFT-insights. [PDF]

BMC Chem
Khalaf NA, Said GE, Abdel-Latif E, Metwally HM.   +3 more
europepmc   +1 more source

Structural Modification of Selected Essential Oil Components for Potential Anticancer Applications: A Review. [PDF]

Pharmaceuticals (Basel)
Khwaza V, Maqanda V.
europepmc   +1 more source

2:1 Adducts Arising from Reactions between Benzynes and 1,3,4-Oxadiazoles. [PDF]

Org Lett
Guzman AL, Kevorkian PV, Hoye TR.
europepmc   +1 more source

Lonidamine-1,3,4-oxadiazole derivatives with antiproliferative effects on HCT116 colon cancer cell lines: biological evaluation, ADMET, and computational studies. [PDF]

RSC Adv
Bhat RM, Priyadarshini AN, Sudhanva MS, Muddapur GV, Alhussieni K, K RK, Keri RS.   +6 more
europepmc   +1 more source

<i>In silico</i> design of novel dihydropteridone derivatives with oxadiazoles as potent inhibitors of MCF-7 breast cancer cells. [PDF]

Front Chem
Aloui M, El Fadili M, Er-Rajy M, Mujwar S, Abuelizz HA, Er-Rahmani S, Menana E.   +6 more
europepmc   +1 more source

Recent Advances: Heterocycles in Drugs and Drug Discovery. [PDF]

Int J Mol Sci
Pibiri I.
europepmc   +1 more source

Promising Norlabdane-Heterocyclic Hybrids: Synthesis, Structural Characterization and Antimicrobial Activity Evaluation. [PDF]

Pharmaceuticals (Basel)
Lungu L, Ciocarlan A, Mangalagiu II, Aricu A.   +3 more
europepmc   +1 more source